Detalhe da pesquisa
1.
Hospitalization Rates in Interstitial Lung Disease: An Analysis of the Pulmonary Fibrosis Foundation Registry.
Am J Respir Crit Care Med
; 2024 Jan 18.
Artigo
Inglês
| MEDLINE | ID: mdl-38236191
2.
Deep Learning Classification of Usual Interstitial Pneumonia Predicts Outcomes.
Am J Respir Crit Care Med
; 209(9): 1121-1131, 2024 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38207093
3.
Pulmonary Fibrosis Stakeholder Summit: A Joint NHLBI, Three Lakes Foundation, and Pulmonary Fibrosis Foundation Workshop Report.
Am J Respir Crit Care Med
; 209(4): 362-373, 2024 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38113442
4.
Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency.
Am J Respir Crit Care Med
; 209(6): 647-669, 2024 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38174955
5.
Effects of nintedanib on symptoms in patients with progressive pulmonary fibrosis.
Eur Respir J
; 63(2)2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38135442
6.
Proteomic Biomarkers of Survival in Idiopathic Pulmonary Fibrosis.
Am J Respir Crit Care Med
; 2023 Oct 17.
Artigo
Inglês
| MEDLINE | ID: mdl-37847691
7.
Clonal Somatic Mutations in Chronic Lung Diseases Are Associated with Reduced Lung Function.
Am J Respir Crit Care Med
; 208(11): 1196-1205, 2023 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37788444
8.
Nintedanib in children and adolescents with fibrosing interstitial lung diseases.
Eur Respir J
; 61(2)2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36041751
9.
Progressive pulmonary fibrosis: an expert group consensus statement.
Eur Respir J
; 61(3)2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36517177
10.
Risk factors for lung function decline in systemic sclerosis-associated interstitial lung disease in a large single-centre cohort.
Rheumatology (Oxford)
; 62(7): 2501-2509, 2023 07 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36377780
11.
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease.
Respir Res
; 24(1): 6, 2023 Jan 09.
Artigo
Inglês
| MEDLINE | ID: mdl-36624431
12.
B7H3 expression and significance in idiopathic pulmonary fibrosis.
J Pathol
; 256(3): 310-320, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34825713
13.
Phase 2B Study of Inhaled RVT-1601 for Chronic Cough in Idiopathic Pulmonary Fibrosis: A Multicenter, Randomized, Placebo-controlled Study (SCENIC Trial).
Am J Respir Crit Care Med
; 205(9): 1084-1092, 2022 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35050837
14.
Alpha-1 Antitrypsin MZ Heterozygosity Is an Endotype of Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med
; 205(3): 313-323, 2022 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34762809
15.
Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement.
Am J Respir Crit Care Med
; 206(4): e7-e41, 2022 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35969190
16.
Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group Perspective.
Am J Respir Crit Care Med
; 206(3): 247-259, 2022 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35353660
17.
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
N Engl J Med
; 381(18): 1718-1727, 2019 10 31.
Artigo
Inglês
| MEDLINE | ID: mdl-31566307
18.
Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial.
Eur Respir J
; 59(3)2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34475231
19.
Effects of nintedanib by inclusion criteria for progression of interstitial lung disease.
Eur Respir J
; 59(2)2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34210788
20.
Lung tissue shows divergent gene expression between chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
Respir Res
; 23(1): 97, 2022 Apr 21.
Artigo
Inglês
| MEDLINE | ID: mdl-35449067